Schedule 13G ownership disclosure
Petros Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 71678J100
Event date: 2021-10-18
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 346,938
- Percent of class
- 5.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000930413-21-001795
- Form type
- SC 13G
- Filer
- Iroquois Capital Management, LLC
- CIK
- CIK 1481867
- Filed
- Oct 22, 2021
- Reporting period
- Oct 18, 2021
- Description
- Schedule 13G beneficial ownership